Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The lack of robust BPC-157 human trialsspecifically Phase II and Phase III studiesmeans that definitive conclusions about its efficacy, optimal dosing, and long-term safety in humans cannot be made
Not critical, but annoying
Neurological damage can result in cognitive changes, such as memory problems, confusion, and difficulty concentrating
Renal effects of drugs that inhibit prostaglandin synthesis
Research demonstrates that BPC-157 upregulates VEGFR2 at both mRNA and protein levels in vascular endothelial cells without increasing VEGF-A itself, effectively sensitizing cells to existing VEGF in the tissue microenvironment rather than simply adding more growth factor signal
While most people can safely have injections, there are a few exceptions
US$ 23.68
US$ 23.50
US$ 25.41
US$ 29.12
US$ 26.23
US$ 27.14
US$ 29.03
US$ 25.24
US$ 26.40
